Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Intangibles (2022 - 2026)

Lucid Diagnostics filings provide 4 years of Intangibles readings, the most recent being $315000.0 for Q4 2025.

  • On a quarterly basis, Intangibles fell 57.2% to $315000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $315000.0, a 57.2% decrease, with the full-year FY2025 number at $315000.0, down 57.2% from a year prior.
  • Intangibles hit $315000.0 in Q4 2025 for Lucid Diagnostics, down from $421000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $5.7 million in Q1 2022 to a low of $315000.0 in Q4 2025.
  • Median Intangibles over the past 4 years was $1.2 million (2023), compared with a mean of $2.5 million.
  • Biggest five-year swings in Intangibles: changed 0.0% in 2023 and later crashed 84.13% in 2024.
  • Lucid Diagnostics' Intangibles stood at $5.3 million in 2022, then tumbled by 73.16% to $1.4 million in 2023, then tumbled by 48.31% to $736000.0 in 2024, then crashed by 57.2% to $315000.0 in 2025.
  • The last three reported values for Intangibles were $315000.0 (Q4 2025), $421000.0 (Q3 2025), and $526000.0 (Q2 2025) per Business Quant data.